A Cohort of Patients Undergoing Percutaneous Coronary Intervention

Launched by SU GUOHAI · Jan 31, 2023

Keywords

ClinConnect Summary

This clinical trial is studying patients who have acute coronary syndrome, a condition where blood flow to the heart is suddenly reduced, leading to serious heart problems. The focus is on understanding the risk factors that contribute to these conditions and how they affect patients' health over time. Participants in the study will undergo a procedure called percutaneous coronary intervention, which helps open blocked arteries in the heart. The researchers will follow these patients for at least two years to gather important information about their recovery and long-term outcomes.

To be eligible for this study, participants must be at least 18 years old and have been diagnosed with acute coronary syndrome, requiring the intervention procedure. Unfortunately, individuals with certain conditions like advanced liver disease or serious infections, as well as those who cannot provide consent, cannot participate. If you join this trial, you can expect regular follow-ups and check-ins, which will help doctors learn more about heart health and improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention.
• • \>18 years old.
• Exclusion Criteria:
• • With malignant tumors, acute infectious diseases and advanced liver diseases.
• • Won't sign an inform consent.